ANGIOGENESIS INHIBITORS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA by Massimiliano Berretta, Luca Rinaldi, Fabrizio Di Benedetto, Arben Lleshi, Valli De Re, Gaetano Facchini, Paolo De Paoli, Raffaele Di Francia

“…Background: Angiogenesis inhibitors have become an important therapeutic approach in the treatment of hepatocellular carcinoma (HCC) patients. …”
Get full text

Angiogenesis inhibitors in the treatment of prostate cancer by Heath Elisabeth I, Hwang Clara

Get full text

Angiogenesis inhibitors from natural sources by Abd Hamid, Roslida, Awang Hamsin, Dayang Erna Zulaikha

“…To date, there are cytotoxic drugs which also exhibit antiangiogenic activity but not angiogenesis inhibitors in whole. In this chapter, we will be discussing selected natural sources including marine products which have been investigated for their antiangiogenic activities. …”
Get full text

Editorial: Angiogenesis and Angiogenesis Inhibitors in Oral Cancer by Abdelhakim Salem, Abdelhakim Salem, Elin Hadler-Olsen, Elin Hadler-Olsen, Ahmed Al-Samadi, Ahmed Al-Samadi

Subjects: Get full text

Marine-Derived Angiogenesis Inhibitors for Cancer Therapy by Ying-Qing Wang, Ze-Hong Miao

“…Angiogenesis inhibitors have been successfully used for cancer therapy in the clinic. …”
Get full text

Angiogenesis Inhibitors in Small Cell Lung Cancer by Agnese Montanino, Anna Manzo, Guido Carillio, Giuliano Palumbo, Giovanna Esposito, Vincenzo Sforza, Raffaele Costanzo, Claudia Sandomenico, Gerardo Botti, Maria C. Piccirillo, Priscilla Cascetta, Giacomo Pascarella, Carmine La Manna, Nicola Normanno, Alessandro Morabito

“…Future challenges are the evaluation of the role of angiogenesis inhibitors in combination with immune- checkpoint inhibitors and chemotherapy in SCLC patients and the identification of predictive biomarkers of response to both agents.…”
Get full text

Angiogenesis inhibitors for the treatment of epithelial ovarian cancer by Gaitskell, K, Rogozińska, E, Platt, S, Chen, Y, Abd El Aziz, M, Tattersall, A, Morrison, J

“…</p> <p><strong>Selection criteria:&nbsp;</strong>RCTs comparing angiogenesis inhibitors with standard chemotherapy, other types of anti‐cancer treatment, other angiogenesis inhibitors with or without other treatments, or placebo/no treatment in a maintenance setting, in women with EOC.…”

Toxicity management of angiogenesis inhibitors: resolution of expert panel by Pavel O. Rumiantsev, Maria I. Volkova, Sergey O. Podvyaznikov, Ilya S. Romanov, Elena K. Shavarova, Eugenia A. Shatokhina

Subjects: Get full text

THERAPEUTIC POTENTIAL OF ANGIOGENESIS INHIBITOR MIXTURES IN CANCER TREATMENT by Patrycja Nowak-Sliwinska, Arjan W. Griffioen

Get full text

Pharmacogenetic-Based Interactions between Nutraceuticals and Angiogenesis Inhibitors by Raffaele Di Francia, Massimiliano Berretta, Giulio Benincasa, Alfredo D’Avino, Sergio Facchini, Domenico Costagliola, Paola Rossi

“…<b>Background:</b> Angiogenesis inhibitors (AIs) have become established as an effective cancer treatment. …”
Get full text

Cancer combination therapies by angiogenesis inhibitors; a comprehensive review by Mohammad Javed Ansari, Dmitry Bokov, Alexander Markov, Abduladheem Turki Jalil, Mohammed Nader Shalaby, Wanich Suksatan, Supat Chupradit, Hasan S. AL-Ghamdi, Navid Shomali, Amir Zamani, Ali Mohammadi, Mehdi Dadashpour

Get full text

Angiogenesis Inhibitors for Colorectal Cancer. A Review of the Clinical Data by Torben Frøstrup Hansen, Camilla Qvortrup, Per Pfeiffer

Get full text

An Optimal Control Approach for the Treatment of Solid Tumors with Angiogenesis Inhibitors by Adam E. Glick, Antonio Mastroberardino

“…By investigating a variety of doses, we determine that the optimal angiogenesis inhibitor dose is in the range of 10–20 mg/kg. …”
Get full text

The impact of angiogenesis inhibitors on survival of patients with small cell lung cancer by Xiaoshun Shi, Xiaoying Dong, Sylvia Young, Allen Menglin Chen, Xiguang Liu, Zhouxia Zheng, Kailing Huang, Di Lu, Siyang Feng, Grant Morahan, Kaican Cai

Subjects: “…angiogenesis inhibitors…”
Get full text

Angiogenesis inhibitor-specific hypertension increases the risk of developing aortic dissection by Kaito Tsujinaka, Yuki Izawa-Ishizawa, Koji Miyata, Toshihiko Yoshioka, Kohei Oomine, Honoka Nishi, Masateru Kondo, Syuto Itokazu, Tatsumi Miyata, Takahiro Niimura, Maki Sato, Fuka Aizawa, Kenta Yagi, Masayuki Chuma, Yoshito Zamami, Mitsuhiro Goda, Keisuke Ishizawa

Subjects: “…Angiogenesis inhibitors…”
Get full text

Review: Angiogenesis inhibitors in the treatment of non-small cell lung cancer by Joline S.W. Lind, Egbert F. Smit

“…The development of angiogenesis inhibitors has shown great promise in the treatment of NSCLC. …”
Get full text

Combination therapy in cancer: effects of angiogenesis inhibitors on drug pharmacokinetics and pharmacodynamics by Ilaria Fuso Nerini, Marta Cesca, Francesca Bizzaro, Raffaella Giavazzi

Subjects: Get full text

Optimizing the use of angiogenesis inhibitor in neovascular age-related macular degeneration by F. A. Bakhritdinova, A. F. Yusupov, Sh. A. Mukhanov

“…Medotilin, which has neuroprotective action, enhances the effect of angiogenesis inhibitors drugs in all forms of neovascular AMD and promotes statistically significant increase of the functional condition of the central retina area, which is confirmed by electroretinography data // Russian Ophthalmological Journal, 2017; 1: 9-14. doi: 10.21516/2072-0076-2017-10-1-9-14.…”
Get full text

Therapeutic Application of Brain-Specific Angiogenesis Inhibitor 1 for Cancer Therapy by Mitra Nair, Chelsea Bolyard, Tae Jin Lee, Balveen Kaur, Ji Young Yoo

Subjects: “…brain-specific angiogenesis inhibitor 1 (BAI1)…”
Get full text

Evaluation of the Effects of Solamargine Extracted from Solanum Nigrum as an Angiogenesis Inhibitor by sodabeh Akbari, Fatemeh kalalinia

Get full text